4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one

C22H16ClN3O4S2 — CID 164620201

IUPAC4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one
SMILESCc1cc(C)c2c(CSc3nnc(CSc4nc5cc(Cl)ccc5o4)o3)cc(=O)oc2c1
InChIInChI=1S/C22H16ClN3O4S2/c1-11-5-12(2)20-13(7-19(27)28-17(20)6-11)9-31-22-26-25-18(30-22)10-32-21-24-15-8-14(23)3-4-16(15)29-21/h3-8H,9-10H2,1-2H3
InChIKeyYBFIGQDLCBUAFI-UHFFFAOYSA-N
MW485.97 g/mol
LogP6.17
Rot. Bonds6

About 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one

4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one (PubChem CID 164620201) has the molecular formula C22H16ClN3O4S2 and a molecular weight of 485.97 g/mol. Its IUPAC name is 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one.

Molecular Properties

Compound Name4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one
PubChem CID164620201
Molecular FormulaC22H16ClN3O4S2
Molecular Weight485.97 g/mol
Exact Mass485.03
IUPAC Name4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one
SMILESCc1cc(C)c2c(CSc3nnc(CSc4nc5cc(Cl)ccc5o4)o3)cc(=O)oc2c1
InChIInChI=1S/C22H16ClN3O4S2/c1-11-5-12(2)20-13(7-19(27)28-17(20)6-11)9-31-22-26-25-18(30-22)10-32-21-24-15-8-14(23)3-4-16(15)29-21/h3-8H,9-10H2,1-2H3
InChIKeyYBFIGQDLCBUAFI-UHFFFAOYSA-N
XLogP6.17
TPSA95.16 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500485.97
LogP ≤ 56.17
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'cumarine', 'substructure': 'N/A'}

Analyze 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one?
The IUPAC name of 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one (CID 164620201) is 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one.
What is the SMILES notation for 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one?
The canonical SMILES for 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one is Cc1cc(C)c2c(CSc3nnc(CSc4nc5cc(Cl)ccc5o4)o3)cc(=O)oc2c1.
What is the InChIKey of 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one?
The InChIKey is YBFIGQDLCBUAFI-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H16ClN3O4S2/c1-11-5-12(2)20-13(7-19(27)28-17(20)6-11)9-31-22-26-25-18(30-22)10-32-21-24-15-8-14(23)3-4-16(15)29-21/h3-8H,9-10H2,1-2H3.
What are the key properties of 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one?
4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one has a molecular weight of 485.97 g/mol, XLogP of 6.17, 6 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[5-[(5-chloro-1,3-benzoxazol-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-5,7-dimethylchromen-2-one is sourced from PubChem (CID 164620201), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).